20/20 Biolabs, Inc.
CIK: 0001139685
Company Information
Industry Services-Testing Laboratories
SIC Code 8734
Entity Type other
State of Incorporation DE
Business Address 9430 KEY WEST AVENUE, ROCKVILLE, MD, 20850
Mailing Address 15810 GAITHER ROAD, SUITE 235, GAITHERSBURG, MD, 20877
Phone 2404536339
Fiscal Year End 1231
EIN 522272107
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| S-1/A IPO registration amendment | January 26, 2026 | View on SEC |
| S-1/A IPO registration amendment | January 21, 2026 | View on SEC |
| S-1 IPO registration statement | December 12, 2025 | View on SEC |
IPO Filings
S-1 December 12, 2025
- Focus on developing advanced diagnostic tests for early disease detection, particularly in infectious diseases and certain types of cancer.
- Demonstrating steadily increasing year-over-year sales and expanding into new markets.
Related Companies
Companies in the same industry (SIC: 8734)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.